Boostrix tdap vaccine syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DR26F79XM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,399
Award facts
- Contract value 100% obligated
- $31,399.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $31,399.26 delivery order to Amerisourcebergen Drug Corp on June 25, 2026, for Boostrix TDAP vaccine syringes (0.5 mL), with ultimate completion by June 26, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a pharmaceutical distributor supplying vaccines, medications, and medical devices to Defense Health Agency and military treatment facilities globally.
Quick answers
Who was awarded contract SPE2DR26F79XM?
SPE2DR26F79XM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 25, 2026.
How much is contract SPE2DR26F79XM worth?
The government has obligated $31,399 on SPE2DR26F79XM.
Is contract SPE2DR26F79XM an order under another contract?
Yes. SPE2DR26F79XM is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F79XM competed?
The extent of competition for SPE2DR26F79XM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award